The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study

References

• Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1–9. doi:10.1016/S0140-6736(06)69561-5.
   PubMed Web of Science ®Google Scholar
• Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean—a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31(12):1263–68. doi:10.1097/INF.0b013e31826ff3a5.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurol. 2013;81(10):928–30. doi:10.1212/WNL.0b013e3182a3516e.
   PubMed Web of Science ®Google Scholar
• World Health Organization.Varicella and herpes zoster vaccines: WHO position paper, June 2014. Weekly Epidemiol Rec= Relevé Épidémiol Hebdomadaire. 2014;89:265–87.
   PubMedGoogle Scholar
• Varela FHP, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccines Immuno. 2019;15:645–57.
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2):132–37.
   PubMed Web of Science ®Google Scholar
• Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, Hur JK, Kim KH, Kim JY, Chung EH, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol. 2014;21(5):762–68.
   PubMed Web of Science ®Google Scholar
• Povey M, Henry O, Bergsaker MAR, Chlibek R, Esposito S, Flodmark CE, Gothefors L, Man S, Silfverdal SA, Štefkovičová M, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2019;19(3):287–97.
   PubMed Web of Science ®Google Scholar
• Van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29(13):2411–20. doi:10.1016/j.vaccine.2011.01.037.
   PubMed Web of Science ®Google Scholar
• Wolfson LJ, Daniels VJ, Pillsbury M, Kurugöl Z, Yardimci C, Kyle J, Dinleyici EC. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PloS One. 2019;14:e0220921.
   PubMed Web of Science ®Google Scholar
• Azzari C, Baldo V, Giuffrida S, Gani R, O’Brien E, Alimenti C, Daniels VJ, Wolfson LJ. The cost-effectiveness of universal varicella vaccination in Italy: a model-based assessment of vaccination strategies. ClinicoEconomics Outcomes Res: CEOR. 2020;12:273.
   PubMed Web of Science ®Google Scholar
• Heininger U, Pillsbury M, Samant S, Lienert F, Guggisberg P, Gani R, O’Brien E, Pawaskar M. Health impact and cost-effectiveness assessment for the introduction of universal varicella vaccination in Switzerland. Pediatr Infect Dis J. 2021;40:e217–e21.
   PubMed Web of Science ®Google Scholar
• Akpo EIH, Cristeau O, Hunjan M, Casabona G. Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom. Clin Infect Dis. 2021;73(11):e3617–e26. doi:10.1093/cid/ciaa1708.
   PubMed Web of Science ®Google Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352(5):450–58. doi:10.1056/NEJMoa042271.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy: experiences from eight Italian regions. Human Vaccines Immun. 2015;11(1):63–71.
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marín-García P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014;32(2):277–83. doi:10.1016/j.vaccine.2013.11.008.
   PubMed Web of Science ®Google Scholar
• Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing universal varicella vaccination in Europe: the path forward. Pediatr Infect Dis J. 2019;38:181–88.
   PubMed Web of Science ®Google Scholar
• Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol. 1999;61:1031–64.
   PubMed Web of Science ®Google Scholar
• Forbes H, Douglas I, Finn A, Breuer J, Bhaskaran K, Smeeth L, Packer S, Langan SM, Mansfield KE, Marlow R, et al. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data. Bmj. 2020;368:16987.
   PubMedGoogle Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatr. 2016;137(3). doi:10.1542/peds.2015-3741.
   PubMed Web of Science ®Google Scholar
• Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, Lewis E, Fireman B, Saddier P. Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study. Pediatr. 2013;131:e1389–e96.
   PubMed Web of Science ®Google Scholar
• Pillsbury M, Carias C, Samant S, Greenberg D, Pawaskar M. Comparison of performance of varicella vaccines via infectious disease modeling. Vaccine. 2020;40:3954–62.
   Web of Science ®Google Scholar
• Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatr. 1976;58(5):692–96. doi:10.1542/peds.58.5.692.
   PubMed Web of Science ®Google Scholar
• Marin M, BSR. Varicella/herpes zoster. 16 ed. Washington, DC: Ameerican Public Health Association; 2015.
   Google Scholar
• Brisson M, Edmunds W, Gay N, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651–69. doi:10.1017/S0950268800004714.
   PubMed Web of Science ®Google Scholar
• Bernstein HH, Rothstein EP, Associates PP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngail A, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatr. 1993;92(6):833–37.
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. Jama. 1997;278:1495–99.
   PubMed Web of Science ®Google Scholar
• Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. Jama. 2004;292(6):704–08. doi:10.1001/jama.292.6.704.
   PubMed Web of Science ®Google Scholar
• Garnett G, Grenfell B. The epidemiology of varicella–zoster virus infections: a mathematical model. Epidemiol Infect. 1992;108(3):495–511. doi:10.1017/S0950268800050007.
   PubMed Web of Science ®Google Scholar
• Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PloS One. 2013;8(4):e60732.
   PubMed Web of Science ®Google Scholar
• Prem K, Cook AR, Jit M, Halloran B. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017;13:e1005697.
   PubMed Web of Science ®Google Scholar
• Brisson M, Gay N, Edmunds W, Andrews N. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19–20):2500–07. doi:10.1016/S0264-410X(02)00180-9.
   PubMed Web of Science ®Google Scholar
• Cohen D, Davidovici B, Smetana Z, Balicer R, Klement E, Mendelson E, Green MS. Seroepidemiology of varicella zoster in Israel prior to large-scale use of varicella vaccines. Infect. 2006;34:208–13.
   PubMed Web of Science ®Google Scholar
• Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of herpes zoster and its complications. J Infect. 2013;67(5):463–69. doi:10.1016/j.jinf.2013.06.016.
   PubMed Web of Science ®Google Scholar
• World population prospects United Nations - Population Division; 2019. https://population.un.org/wpp/Download/Standard/Fertility/
   Google Scholar
• Stein-Zamir C, Rishpon S. The national immunization technical advisory group in Israel. Isr J Health Policy Res. 2021;10(1):7. doi:10.1186/s13584-021-00442-4.
   PubMed Web of Science ®Google Scholar
• Pharma-Soft. Medicine price list. https://www.pharma-soft.co.il/product
   Google Scholar
• Ginsberg G, Somekh E. Cost containment analysis of childhood vaccination against varicella in Israel. J Infect. 2004;48(2):119–33. doi:10.1016/S0163-4453(03)00079-3.
   PubMed Web of Science ®Google Scholar
• Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17(1):1–16.
   PubMedGoogle Scholar
• Ministry of Health, State of Israel. Ministry of health tariff; 2021. https://www.gov.il/he/Departments/DynamicCollectors/moh-price-list?skip=0
   Google Scholar
• Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:1–11.
   PubMed Web of Science ®Google Scholar
• Littlewood KJ, Ouwens MJ, Sauboin C, Tehard B, Alain S, Denis F. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster. Clin Ther. 2015;37:830–41. e7.
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38–47. doi:10.1017/S0950268808000678.
   PubMed Web of Science ®Google Scholar
• National Insurance Institute, State of Israel. Average wage according to sections 1 and 2 of the national insurance law. https://www.btl.gov.il/Mediniyut/GeneralData/Pages/%D7%A9%D7%9B%D7%A8%20%D7%9E%D7%9E%D7%95%D7%A6%D7%A2.aspx
   Google Scholar
• Geneva: World Health Organization. WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Licence: CC BY-NC-SA 3.0 IGO2019. https://apps.who.int/iris/bitstream/handle/10665/329389/WHO-IVB-19.10-eng.pdf
   Google Scholar
• Oakes K. Vaccines Europe makes the case for vaccine-specific HTA: regulatory affairs professionals society (RAPS); 2021 [accessed 2021 Sep 21]. https://www.raps.org/news-and-articles/news-articles/2021/9/vaccines-europe-makes-the-case-for-vaccine-specifi
   Google Scholar
• Pawaskar M, Burgess C, Pillsbury M, Wisløff T, Flem E. Clinical and economic impact of universal varicella vaccination in Norway: a modeling study. PloS One. 2021;16:e0254080.
   PubMed Web of Science ®Google Scholar